Personal cleansing compositions with increased deposition of polyacrylate microcapsules

Abstract

A personal cleansing composition that increases the deposition and retention of benefit agent containing polyacrylate microcapsules onto hair and/or skin. The personal cleansing composition is based on the combination of anionic charged polyacrylate microcapsules, cationic deposition polymers, detersive surfactant, and a carrier.

Description

FIELD OF THE INVENTION

The present invention relates to personal cleansing compositions containing polyacrylate microcapsules, wherein the polyacrylate microcapsules have increased deposition onto hair and/or skin.

BACKGROUND OF THE INVENTION

Many of the personal cleansing products in the market today work to deliver benefits to hair and/or skin by depositing benefit agents such as perfumes, moisturizers, and skin care agents onto the desired situs. As a result, there is a desire to maximize the effectiveness of such benefit agents by increasing their delivery and retention. One method of achieving this objective is to encapsulate such benefit agents in microcapsules. While these microcapsules are able to encapsulate a wide variety of benefit agents and deliver them to the desired situs, it is still difficult to improve the retention and delivery efficiencies of such benefit agents. Such agents may be lost due to the agents' physical or chemical characteristics, or such agents may be incompatible with other compositional components or the situs that is being treated. Consumers today desire personal cleansing compositions that deposit and retain encapsulated benefit agents onto hair and/or skin, even after an extended period of time.

One known method for improving the deposition of microcapsules onto the situs during treatment involves the use of certain cationic deposition polymers. However, this alone does not necessarily ensure adequate deposition of microcapsules.

Accordingly, there is a need for a personal cleansing composition that provides an increased deposition of encapsulated benefit agents. In addition, there is a need for a polymer system that associates with microcapsule surfaces, and that when sheared, allows the encapsulated benefit agents to be released. Furthermore, there is a need for a personal cleansing composition that provides an increased retention of encapsulated benefit agents onto the situs for an extended period of time.

SUMMARY OF THE INVENTION

A personal cleansing composition comprising: from about 0.001% to about 10% of an anionic charged polyacrylate microcapsule; from about 0.01% to about 2% of a cationic deposition polymer; from about 2% to about 50% of a detersive surfactant; and a carrier.

A method of making a personal cleansing composition, wherein the composition is formed by a process comprising the steps of: coating a polyacrylate microcapsule with an anionic emulsifier to form an anionic polyacrylate microcapsule; combining the anionic polyacrylate microcapsule with a cationic deposition polymer to form a premix; adding the premix to a detersive composition comprising surfactant and a carrier.

A method of making a personal cleansing composition, wherein the composition is formed by a process comprising the steps of: coating a polyacrylate microcapsule with an anionic emulsifier to form an anionic polyacrylate microcapsule; combining the anionic polyacrylate microcapsule with a cationic deposition polymer to form a premix; adding the premix to an anionic surfactant; adding the resulting composition of step (c) to a detersive composition comprising surfactant and a carrier.

DETAILED DESCRIPTION OF THE INVENTION

In all embodiments of the present invention, all percentages are by weight of the total composition, unless specifically stated otherwise. All ratios are weight ratios, unless specifically stated otherwise. All ranges are inclusive and combinable. The number of significant digits conveys neither a limitation on the indicated amounts nor on the accuracy of the measurements. All numerical amounts are understood to be modified by the word “about” unless otherwise specifically indicated. Unless otherwise indicated, all measurements are understood to be made at 25° C. and at ambient conditions, where “ambient conditions” means conditions under about one atmosphere of pressure and at about 50% relative humidity. All such weights as they pertain to listed ingredients are based on the active level and do not include carriers or by-products that may be included in commercially available materials, unless otherwise specified.

DEFINITIONS

As used herein, the term “personal cleansing composition” includes, unless otherwise indicated, any personal cleansing composition that can be applied to the keratinaceous surfaces of the body including the skin and/or hair. The personal cleansing compositions can be, for example, formulated as cleaning bars, liquids, emulsions, shower gels, powders, sticks, pastes, mouthwashes, foam baths, shave prep products, and devices used for shaving.

As used herein, the term “fluid” includes liquids and gels.

As used herein, the terms “microcapsule,” “encapsulated benefit agents,” and “solid particulates,” refers to polyacrylate microcapsules.

As used herein, the term “premix” refers to the combination of anionic polyacrylate microcapsules with cationic deposition polymers.

As used herein, the term “situs” includes hair and skin.

As used herein, the articles including “a” and “an” when used in a claim, are understood to mean one or more of what is claimed or described.

As used herein, the terms “include,” “includes,” and “including,” are meant to be non-limiting.

The test methods disclosed in the Test Methods Section of the present application should be used to determine the respective values of the parameters of Applicants' inventions.

Unless otherwise noted, all component or composition levels are in reference to the active portion of that component or composition, and are exclusive of impurities, for example, residual solvents or by-products, which may be present in commercially available sources of such components or compositions.

All percentages and ratios are calculated by weight unless otherwise indicated. All percentages and ratios are calculated based on the total composition unless otherwise indicated.

It should be understood that every maximum numerical limitation given throughout this specification includes every lower numerical limitation, as if such lower numerical limitations were expressly written herein. Every minimum numerical limitation given throughout this specification will include every higher numerical limitation, as if such higher numerical limitations were expressly written herein. Every numerical range given throughout this specification will include every narrower numerical range that falls within such broader numerical range, as if such narrower numerical ranges were all expressly written herein.

Benefits of Anionic Polyacrylate Microcapsules

Consumers desire personal cleansing compositions that deposit and retain encapsulated benefit agents onto their hair and/or skin during the cleansing process. Traditionally, a variety of approaches have been employed to improve deposition of microcapsules, including (1) using specific block copolymers to covalently bind to the microcapsules, and (2) using cationic water soluble polymers to coat the microcapsules in order to increase the affinity of the microcapsules to the substrate of interest. However, it is desired to have improved deposition over the traditional approaches.

It has been surprisingly found that a synergy exists between anionic emulsifiers and polyacrylate microcapsules, resulting in anionic polyacrylate microcapsules. When such anionic microcapsules are mixed with cationic deposition polymers, microstructures are formed at the surface of the anionic polyacrylate. Such anionic microstructures display high viscoelasticity, remain in tact even upon dilution during cleansing, and display strong adhesion to keratinaceous hair and/or skin surfaces. Combined with cleansing compositions, these properties result in improved delivery efficiency of the encapsulated benefit agents to hair and/or skin.

It is believed that the personal cleansing compositions comprising anionic polyacrylate microcapsules, along with specific cationic deposition polymers, delivers a higher deposition rate than personal cleansing compositions containing non-anionic polyacrylates. In addition, anionic polyacrylate microcapsules with specific cationic deposition polymers also have a higher retention rate on the situs even over an extended period of time. Applicants surprising discovery of adding anionic emulsifier to microcapsules to form anionic microcapsules can be accomplished by either: (1) adding the anionic emulsifier to an already formed microcapsule or (2) allowing the anionic emulsifier to associate with the microcapsule surface during the microcapsule making process. Once formed, the anionic polyacrylate microcapsules are combined with the specific cationic polymer(s) chosen to form a premix for addition to an anionic surfactant containing personal cleansing composition.

Anionic Emulsifier

The addition of an anionic emulsifier forms a microstructure with a specified cationic deposition polymer at the external surface of the microcapsules, i.e., the anionic emulsifier is at least a part of the external surface of the microcapsules, or is physically or chemically bound to the external surface of the microcapsules. Such physical bindings include, for example, hydrogen bonding, ionic interactions, hydrophobic interactions, and electron transfer interactions. Such chemical bindings include, for example, covalent bindings such as covalent grafting and crosslinking.

The anionic emulsifier is present at a level by weight of from about 0.1% to about 40%, from about 0.5% to about 10%, or from about 0.5% to about 5%, by weight of the polyacrylate microcapsule.

A variety of anionic emulsifiers can be used in the personal cleansing composition of the present invention as described below. The anionic emulsifiers include, by way of illustrating and not limitation, water-soluble salts of alkyl sulfates, alkyl ether sulfates, alkyl isothionates, alkyl carboxylates, alkyl sulfosuccinates, alkyl succinamates, alkyl sulfate salts such as sodium dodecyl sulfate, alkyl sarcosinates, alkyl derivatives of protein hydrolyzates, acyl aspartates, alkyl or alkyl ether or alkylaryl ether phosphate esters, sodium dodecyl sulphate, phospholipids or lecithin, or soaps, sodium, potassium or ammonium stearate, oleate or palmitate, alkylarylsulfonic acid salts such as sodium dodecylbenzenesulfonate, sodium dialkylsulfosuccinates, dioctyl sulfosuccinate, sodium dilaurylsulfosuccinate, poly(styrene sulfonate) sodium salt, isobutylene-maleic anhydride copolymer, gum arabic, sodium alginate, carboxymethylcellulose, cellulose sulfate and pectin, poly(styrene sulfonate), isobutylene-maleic anhydride copolymer, gum arabic, carrageenan, sodium alginate, pectic acid, tragacanth gum, almond gum and agar; semi-synthetic polymers such as carboxymethyl cellulose, sulfated cellulose, sulfated methylcellulose, carboxymethyl starch, phosphated starch, lignin sulfonic acid; and synthetic polymers such as maleic anhydride copolymers (including hydrolyzates thereof), polyacrylic acid, polymethacrylic acid, acrylic acid butyl acrylate copolymer or crotonic acid homopolymers and copolymers, vinylbenzenesulfonic acid or 2-acrylamido-2-methylpropanesulfonic acid homopolymers and copolymers, and partial amide or partial ester of such polymers and copolymers, carboxymodified polyvinyl alcohol, sulfonic acid-modified polyvinyl alcohol and phosphoric acid-modified polyvinyl alcohol, phosphated or sulfated tristyrylphenol ethoxylates.

In addition, it is desirable to use anionic emulsifiers that have acrylate functionality since these can be covalently linked to the shell portion of the polyacrylate microcapsules during the microcapsule making process. Anionic emulsifiers useful herein include, but aren't limited to: poly(meth)acrylic acid; copolymers of (meth)acrylic acids and its (meth)acrylates with C1-22 alkyl, C1-C8 alkyl, butyl; copolymers of (meth)acrylic acids and (meth)acrylamide; Carboxyvinylpolymer; acrylate copolymers such as Acrylate/C10-30 alkyl acrylate crosspolymer, Acrylic acid/vinyl ester copolymer/Acrylates/Vinyl Isodecanoate crosspolymer, Acrylates/Palmeth-25 Acrylate copolymer, Acrylate/Steareth-20 Itaconate copolymer, and Acrylate/Celeth-20 Itaconate copolymer; Polystyrene sulphonate, copolymers of methacrylic acid and acrylamidomethylpropane sulfonic acid, and copolymers of acrylic acid and acrylamidomethylpropane sulfonic acid; carboxymethycellulose; carboxy guar; copolymers of ethylene and maleic acid; and acrylate silicone polymer. Neutralizing agents may be included to neutralize the anionic emulsifiers herein. Non-limiting examples of such neutralizing agents include sodium hydroxide, potassium hydroxide, ammonium hydroxide, monoethanolamine, diethanolamine, triethanolamine, diisopropanolamine, aminomethylpropanol, tromethamine, tetrahydroxypropyl ethylenediamine, and mixtures thereof. Commercially available anionic emulsifiers include, for example, Carbomer supplied from Noveon under the tradename Carbopol 981 and Carbopol 980; Acrylates/C10-30 Alkyl Acrylate Crosspolymer having tradenames Pemulen TR-1, Pemulen TR-2, Carbopol 1342, Carbopol 1382, and Carbopol ETD 2020, all available from Noveon; sodium carboxymethylcellulose supplied from Hercules as CMC series; and Acrylate copolymer having a tradename Capigel supplied from Seppic. In another embodiment, anionic emulsifiers are carboxymethylcelluloses.

Polyacrylate Microcapsules

Various processes for microencapsulation, and exemplary methods and materials, are set forth in U.S. Pat. No. 6,592,990; U.S. Pat. No. 2,730,456; U.S. Pat. No. 2,800,457; U.S. Pat. No. 2,800,458; and U.S. Pat. No. 4,552,811. Each patent described throughout this application is incorporated herein by reference to the extent each provides guidance regarding microencapsulation processes and materials.

The present invention teaches a low permeability microcapsule comprising a core material and a wall material at least partially surrounding, and in one embodiment, completely surrounding, a core material. In the present invention, the polyacrylate microcapsules are benefit agent microcapsule particulates which encapsulate benefit agents by capsule wall materials comprised of polymers.

Capsule wall materials useful herein include, for example, those formed from melamine-formaldehyde or urea-formaldehyde condensates, melamine-resorcinol or urea-resorcinol condensates, as well as similar types of aminoplasts, gelatin, polyurethane, polyamide, polyolefin, polysaccaharide, protein, silicone, lipid, modified cellulose, gums, polyacrylate, polyphosphate, polystyrene, and polyesters, or combinations of these materials. In another embodiment, a wall material that provides low permeability is polyacrylate.

The benefit agents of the core may comprise a material selected from the group consisting of perfumes; brighteners; enzymes; perfumes; skin care agents, conditioning agents, moisturizers, thickeners; anti-microbial agents; sensates in one aspect a cooling agent; attractants, in one aspect a pheromone; anti-bacterial agents; dyes; pigments; bleaches; and mixtures thereof.

The present invention may further comprise one or more anti-fungal or anti-microbial actives. When present, the antimicrobial bar composition can include from about 0.001% to about 5%, in another embodiment from about 0.01% to about 1.5%, and in another embodiment from about 0.1% to about 1%, by weight of the personal cleansing composition, of the antibacterial agents. Examples of antimicrobial agents that can be used herein include a pyrithione or a polyvalent metal salt of pyrithione such as a zinc salt of 1-hydroxy-2-pyridinethione (known as “zinc pyrithione” or “ZPT”), carbanilides, for example, triclocarban (also known as trichlorocarbanilide), triclosan, a halogenated diphenylether available as DP-300 from Ciba-Geigy, hexachlorophene, 3,4,5-tribromosalicylanilide, and salts of 2-pyridinethiol-1-oxide, salicylic acid and other organic acids. Other suitable antimicrobial agents are described in detail in U.S. Pat. No. 6,488,943 (referred to as antimicrobial actives).

The polyacrylate microcapsules useful herein are those releasing the benefit agents for a period of time after initial application. Potential trigger mechanisms for release of the encapsulated benefit agents may include, but are not limited to, mechanical forces, dehydration, light, pH, temperature, or even changes in ionic strength.

Process of Making Anionic Polyacrylate Microcapsules

An anionic polyacrylate microcapsule can be formed by either: (1) coating an already formed microcapsule with an anionic emulsifier; or (2) adding the anionic emulsifier to the microcapsule during the microcapsule making process. Any known method for generating a microcapsule is useful herein. Example methods for making polyacrylate microcapsules are disclosed in U.S. Patent Application 61/328,949; U.S. Patent Application 61/328,954; U.S. Patent Application 61/328,962; and U.S. Patent Application 61/328,967.

In one embodiment, polyacrlyate microcapsules are formed from water in oil, or oil in water emulsifications. During the polyacrylate microcapsule making process, a first composition is prepared as an oil phase. The oil phase may comprise oil; an oil soluble or dispersible primary, secondary, or tertiary amine; a multifunctional acrylate or methacrylate monomer or oligomer; an oil soluble acid; an initiator, and combinations thereof. In one embodiment, a nitrogen blanket is employed while the solution is mixed. Gradually, the temperature is increased to create a first composition reaction product. After the first composition reaction product is formed, a second composition is added to the reaction product.

The second composition is prepared as a water phase. The water phase may comprise water; an emulsifier that may be water soluble or water dispersible polymer or copolymer; at least one water phase initiator; one or more of an alkali or alkali salt, and combinations thereof. By water phase initiator, it is meant that the initiator is soluble or dispersible in water.

The second composition is then added to the oil solution of the first composition reaction product. This addition creates an oil-in-water emulsion. The reaction of the first composition in the presence of the second composition results in the formation of a low permeability microcapsule wall. The emulsion is further heated for a time and temperature sufficient to decompose the free radicals which are present in either one or both of the oil and water phases.

Furthermore, the polymerization of the monomers and oligomers in the oil phase causes a precipitation of the polymerized material. The precipitation of microcapsule wall material forms at the interface of the water and oil phases.

The anionic polyacrylate microcapsule is contained in the composition at a level by weight of from about 0.01% to about 50%, from about 0.05% to about 10%, from about 0.1% to about 8%, or from about 0.25% to 3%.

The anionic polyacrylate microcapsules useful herein are those having a particle size of from about 1 micron to about 80 microns, from about 2 microns to about 50 microns, and from about 5 microns to about 30 microns.

A. Coating a Microcapsule

In one embodiment of the invention, the anionic emulsifier is added to an already formed polyacrylate microcapsule. The anionic emulsifier attaches to the surface of the microcapsule through hydrogen bonding, van der Waals forces, ionic interactions, hydrophobic interactions, or chemical reactions. In one aspect, the anionic emulsifier surrounds at least a part of the external surface of the polyacrylate microcapsule, or is physically or chemically bound to the external surface of the polyacrylate microcapsule.

B. Adding Anionic Emulsifier to a Microcapsule

In another embodiment, the anionic emulsifier associates with the microcapsule surface during the microcapsule making process. When making the microcapsule, the anionic emulsifier is solubilized in an aqueous phase, which may optionally contain a free radical initiator, prior to emulsification of the oil. The excess aqueous phase is then added to the oil phase to form an oil-in-water emulsion. The emulsion is then heated for a time and at a temperature sufficient to decompose the free radicals which are positioned in one or both of the oil and aqueous phases. Microcapsule wall material is thereby formed at the interface of the water and oil phases. In one embodiment, when the emulsifier is comprised of acrylate moieties, the emulsifier may become chemically bound to the interfacial wall material.

C. Forming the Premix

Once the anionic polyacrlyate microcapsule is formed by either formation step, the anionic polyacrylate microcapsule is added to a specific cationic deposition polymer to form a premix. It has been surprisingly found that the anionic charge on the polyacrylate microcapsule leads to the formation of a microstructure on the shell of the microcapsule when combined with a cationic deposition polymer in the premix. This premix exhibits anionic polyacrylate microcapsules that have a higher viscoelasticity to the hair and/or skin than microcapsules without an anionic charge and specific cationic deposition polymer thus giving a benefit to the situs.

Slurry/Aggolmerate

In one embodiment, the anionic polyacrylate microcapsules are contained in a slurry. The slurry may be combined with an adjunct ingredient to form a composition, for example, a conditioning consumer product.

In one aspect, the slurry may comprise one or more processing aids, selected from the group consisting of water, aggregate inhibiting materials such as divalent salts; particle suspending polymers such as xanthan gum, guar gum, and caboxy methyl cellulose. In another embodiment, said processing aids may be selected from the group consisting of amphoteric surfactants such as cocamidopropyl betaine (CAPB), zwitterionic surfactants, cationic swellable polymers, latex particles such as acrylic based ester Rheovis CDE, and mixtures thereof.

In one aspect, the slurry may comprise a carrier selected from the group consisting of polar solvents, including but not limited to, water, ethylene glycol, propylene glycol, polyethylene glycol, glycerol; nonpolar solvents, including but not limited to, mineral oil, perfume raw materials, silicone oils, hydrocarbon paraffin oils, and mixtures thereof.

In another embodiment, the anionic polyacrylate microcapsules are contained in an agglomerate with a second material. In one aspect, said second materials may comprise a material selected from the group consisting of silicas, citric acid, sodium carbonate, sodium sulfate, sodium chloride, and binders such as sodium silicates, modified celluloses, polyethylene glycols, polyacrylates, polyacrylic acids, zeolites and mixtures thereof.

Cationic Deposition Polymer

The personal cleansing composition of the present invention comprises a cationic deposition polymer that forms a premix when added to the anionic polyacrylate microcapsules. Any known natural or synthetic cationic deposition polymer can be used herein. Examples include those polymers disclosed in U.S. Pat. No. 6,649,155; U.S. patent application Ser. No. 12/103,902; U.S. Patent Publication 2008/0206355; and U.S. Patent Publication No. 2006/0099167A1.

The cationic deposition polymer is included in the composition at a level from about 0.01% to about 2%, in one embodiment from about 1.5% to about 1.9%, in another embodiment from about 1.8% to about 2.0%, in view of providing the benefits of the present invention.

The cationic deposition polymer is a water soluble polymer with a charge density from about 0.5 milliequivalents per gram to about 12 milliequivalents per gram. The cationic deposition polymer used in the composition has a molecular weight of about 100,000 Daltons to about 5,000,000 Daltons. The cationic deposition polymer is a low charge density cationic polymer.

In one embodiment, the cationic deposition polymer is a synthetic cationic deposition polymer. A variety of synthetic cationic deposition polymers can be used including mono- and di-alkyl chain cationic surfactants. In one embodiment, mono-alkyl chain cationic surfactants are chosen including, for example, mono-alkyl quaternary ammonium salts and mono-alkyl amines. In another embodiment, di-alkyl chain cationic surfactants are used and include, for example, dialkyl (14-18) dimethyl ammonium chloride, ditallow alkyl dimethyl ammonium chloride, dihydrogenated tallow alkyl dimethyl ammonium chloride, distearyl dimethyl ammonium chloride, dicetyl dimethyl ammonium chloride, and mixtures thereof.

In another embodiment, the cationic deposition polymer is a naturally derived cationic polymer. The term, “naturally derived cationic polymer” as used herein, refers to cationic deposition polymers which are obtained from natural sources. The natural sources may be polysaccharide polymers. Therefore, the naturally derived cationic polymer may be selected from the group comprising starches, guar, cellulose, Cassia, locust bean, Konjac, Tara, galactomannan, tapioca, and synthetic polymers. In a further embodiment, cationic deposition polymers are selected from Mirapol 100S (Rhodia), Jaguar C17, polyDADMAC, Tapioca starch (Akzo), polyTriquat, and mixtures thereof.

Forming a Premix

The cationic deposition polymer and the anionic polyacrylate microcapsule are mixed to form a premix before addition to the personal cleansing composition comprising a detersive surfactant and a carrier.

The weight ratio of the anionic polyacrylate microcapsule to the cationic deposition polymer (based on the dry weight of the anionic microcapsules and the dry weight of the cationic deposition polymer) is from about 0.5:30 to about 20:1, from about 5:15 to about 15:1, and from about 5:1 to about 12:1. It is believed that too much cationic polymer may not provide enhanced and/or prolonged benefits to the benefit agent microcapsules due to the formation of excess cationic polymer coating on the capsule wall. This excess coating may prevent the microcapsule wall from breaking and releasing the benefit agents.

Microcapsules and anionic emulsifiers may be dispersed in solvents such as water while mixing with the cationic deposition polymer. In one embodiment, the amount of water present is from about 90% to about 50%, in another embodiment from about 70% to about 50%, and in another embodiment from about 60% to about 50%. In one embodiment of the invention, the anionic emulsifiers associate with the microcapsule walls to form anionic polyacrylate microcapsules prior to their mixing with cationic deposition polymers.

Detersive Composition

The detersive composition can be all aqueous phase or may comprise both an oil phase and an aqueous phase. In one embodiment, the detersive composition has both an oil phase and an aqueous phase. After being added to the detersive composition, the polyacrylate microcapsules reside in the aqueous phase of such embodiments.

The detersive composition may comprise any combination of the following components:

A. Detersive Surfactant

The personal cleansing composition of the present invention includes a detersive surfactant. The detersive surfactant provides cleaning performance to the composition. The detersive surfactant in turn comprises anionic, nonionic, cationic, zwitterionic, amphoteric surfactants, soap, or combinations thereof. Various examples and descriptions of detersive surfactants are set forth in U.S. Pat. No. 6,649,155; U.S. patent application Ser. No. 12/103,902; and U.S. Patent Publication 2008/0206355, and are incorporated herein for reference.

The concentration of the anionic surfactant component in the cleansing composition should be sufficient to provide the desired cleaning and lather performance, and generally ranges from about 2% to about 50%, from about 8% to about 30%, from about 10% to about 25%, or from about 12% to about 22%.

For example, according to one embodiment, the surfactant can comprise one or more linear anionic surfactants such as ammonium lauryl sulfate, ammonium laureth sulfate, sodium lauryl sulfate, sodium laureth sulfate, potassium laureth sulfate, sodium lauryl sarcosinate, sodium lauroyl sarcosinate, lauryl sarcosine, cocoyl sarcosine, ammonium cocoyl sulfate, potassium lauryl sulfate, and combinations thereof. In one embodiment, the surfactant comprises sodium laureth(n) sulfate, hereinafter SLEnS, where n defines the average moles of ethoxylation. In another embodiment, n ranges from greater than 0 to 8, alternatively from about 1 to about 3, alternatively about 1. It is understood that a material such as SLEnS, for example, can comprise a significant amount of molecules which have no ethoxylate, 1 mole ethoxylate, 2 mole ethoxylate, 3 mole ethoxylate, and so on in a distribution which can be broad, narrow or truncated. For example, SLE1S can comprise a significant amount of molecules which have no ethoxylate, 1 mole ethoxylate, 3 mole ethoxylate, and so on in a distribution which can be broad, narrow or truncated and still comprise SLE1S where the average of the distribution is about 1.

The surfactant can also comprises one or more branched anionic surfactants and monomethyl branched anionic surfactants such as sodium trideceth sulfate, sodium tridecyl sulfate, sodium C_12-13 alkyl sulfate, and C_12-13 pareth sulfate and sodium C_12-13 pareth-n sulfate.

Suitable amphoteric or zwitterionic detersive surfactants for use in the personal cleansing composition herein include those which are known for use in personal care cleansing. Concentrations of such amphoteric detersive surfactants range from about 0.5% to about 20%, and from about 1% to about 10%. Non limiting examples of suitable zwitterionic or amphoteric surfactants are described in U.S. Pat. No. 5,104,646 (Bolich Jr. et al.), U.S. Pat. No. 5,106,609 (Bolich Jr. et al.).

Amphoteric surfactant suitable for use in the personal cleansing composition described herein include those that are broadly described as derivatives of aliphatic secondary and tertiary amines in which the aliphatic radical can be straight or branched chain and wherein one of the aliphatic substituents contains from about 8 to about 18 carbon atoms and one contains an anionic water solubilizing group, e.g., carboxy, sulfonate, sulfate, phosphate, or phosphonate. Examples of compounds falling within this definition include sodium 3-dodecyl-aminopropionate, sodium 3-dodecylaminopropane sulfonate, sodium lauryl sarcosinate, N-alkyltaurines such as the one prepared by reacting dodecylamine with sodium isethionate according to the teaching of U.S. Pat. No. 2,658,072, N-higher alkyl aspartic acids such as those produced according to the teaching of U.S. Pat. No. 2,438,091, and the products described in U.S. Pat. No. 2,528,378. In an embodiment, the surfactant included in the personal cleansing composition described herein can comprise an amphoteric surfactant that is selected from the group consisting of sodium lauroamphoacetate, sodium cocoamphoactetate, disodium lauroamphoacetate disodium cocodiamphoacetate, and mixtures thereof.

Zwitterionic surfactants suitable for use in the surfactant of the personal cleansing composition described herein include those that are broadly described as derivatives of aliphatic quaternary ammonium, phosphonium, and sulfonium compounds, in which the aliphatic radicals can be straight or branched chain, and wherein one of the aliphatic substituents contains from about 8 to about 18 carbon atoms and one contains an anionic group, e.g., carboxy, sulfonate, sulfate, phosphate, or phosphonate. In one embodiment, the zwitterionic surfactant included in the personal cleansing composition described herein can comprise one or more betaines such as cocoamidopropyl betaine.

B. Aqueous Carrier

The formulations of the present invention can be in the form of pourable liquids (under ambient conditions). Such compositions will therefore typically comprise an aqueous carrier, which is present at a level of from about 20% to about 95%, or even from about 60% to about 85%. The aqueous carrier may comprise water, or a miscible mixture of water and organic solvent, and in one aspect may comprise water with minimal or no significant concentrations of organic solvent, except as otherwise incidentally incorporated into the composition as minor ingredients of other essential or optional components.

The carrier useful in the present invention includes water and water solutions of lower alkyl alcohols and polyhydric alcohols. The lower alkyl alcohols useful herein are monohydric alcohols having 1 to 6 carbons, in one aspect, ethanol and isopropanol. The polyhydric alcohols useful herein include propylene glycol, hexylene glycol, glycerin, and propane diol.

Method of Manufacture

The personal cleansing compositions of the present invention can be prepared by the process comprising: 1) coating a polyacrylate microcapsule with an anionic emulsifier to form an anionic polyacrylate microcapsule; 2) combining the anionic polyacrylate microcapsule with a cationic deposition polymer to form a premix; and 3) adding the premix to a detersive composition comprising surfactant and a carrier.

In another embodiment, the personal cleansing compositions of the present invention can be prepared by the process comprising: 1) coating a polyacrylate microcapsule with an anionic emulsifier to form an anionic polyacrylate microcapsule; 2) combining the anionic polyacrylate microcapsule with a cationic deposition polymer to form a premix; 3) adding the premix to a anionic surfactant; and 4) adding the resulting composition of step (3) to a detersive composition comprising surfactant and a carrier.

It has been unexpectedly found that the association of anionic polyacrylate microcapsules combined with cationic deposition polymers has a higher viscoelasticity than in the absence of the mixed components thus giving a better adhesion of the anionic microcapsules to the hair.

For example, when an anionic emulsifier comprising a copolymer of acrylic acid and butyl acrylate (molecular weight of 40,000 g/mol), is mixed with various cationic polymers to form a polymer premix, the result is a significant increase in viscoelasticity. This increase indicates a strong polyelectrolyte interaction which is exemplified in the increase in viscoelastic component G′ as the quantity of cationic polymer increases (See Table 1)

TABLE 1
Viscoelasticity as a function of anionic:cationic polymer premix ratio.
	Anionic	Cationic	Anionic
Sample	Emulsifier	Polymer	Surfactant	G′ at 1 Hz	G″ at 1 Hz
Description	(wt %)	(wt %)	(wt %)	(Pascals)	(Pascals)
1:5	5.10%	25.48%	0.00%	0.369	6.55
Anionic:
Cationic
1:10	2.78%	27.79%	0.00%	0.178	7.22
Anionic:
Cationic
1:20	1.46%	29.12%	0.00%	0.233	7.92
Anionic:
Cationic

Furthermore, when an anionic surfactant is added to the polymer premix, a substantial increase in viscoelasticity is also noted. Such an increase in viscoelasticity is influenced by the strength of the association between the cationic deposition polymer and the anionic surfactant. This is exemplified in the increase in viscoelastic component G′ upon addition of anionic surfactant to the premix (See Table 2).

TABLE 2
Viscoelasticity as a function of anionic surfactant addition to polymer
premix.
	Anionic	Cationic	Anionic	G′ at 1 Hz	G″ at 1 Hz
Sample ID	Emulsifier	Polymer	Surfactant	(Pascals)	(Pascals)
1:5	3.05%	15.25%	10.87%	42	105.6
Anionic:
Cationic
1:10	1.65%	16.48%	11.74%	37.1	7.1
Anionic:
Cationic
1:20	0.86%	17.17%	12.23%	118.2	133.9
Anionic:
Cationic

In one embodiment of the invention, an anionic emulsifier is covalently bonded to the outer wall of the polyacrylate microcapsule by incorporating the anionic emulsifier during the microcapsule making process. In another embodiment, the anionic emulsifier is added to the slurry comprising a fully formed polyacrylate microcapsule. After forming the anionic polyacrylate microcapsule through either step, a cationic deposition polymer is then added to the anionic microcapsule to form a viscoelastic premix. When this premix is then combined with an anionic surfactant, an association of polymers forms a microstructure on the anionic polyacrylate microcapsule wall. The microstructure forms even upon dilution of the personal cleansing composition. Once formed, the high viscosity of the polymer association microstructure results in an anionic polyacrylate microcapsule that maintains its microcapsule structure even upon dilution of the personal cleansing composition. In addition, the microcapsule structure provides multiple points of contact to the substrate which works to increase the amount of time the microcapsule is on the situs.

The polyacrylate microcapsules of the present invention can be formulated into any suitable form and prepared by any process chosen by the formulator, non-limiting examples of which are described in U.S. Pat. No. 5,879,584; U.S. Pat. No. 5,691,297; U.S. Pat. No. 5,574,005; U.S. Pat. No. 5,569,645; U.S. Pat. No. 5,565,422; U.S. Pat. No. 5,516,448; U.S. Pat. No. 5,489,392; U.S. Pat. No. 5,486,303 all of which are incorporated herein by reference.

Product Forms

The personal cleansing compositions of the present invention can be in the form of rinse-off products or leave-on products, and can be formulated in a wide variety of product forms, including but not limited to creams, gels, emulsions, mousses and sprays.

In one embodiment, the personal cleansing composition is in the form of a gel comprising less than about 45% water. In such embodiment, the gel may have a neat viscosity of about 1,000 cps to about 10,000 cps. The neat viscosity of a gel can be defined as the viscosity of the fluid at a shear rate of 1/sec. Scientifically, viscosity is the ratio of shear stress to shear rate. In some embodiments, the range of shear rates for gels is from 0.01/sec to 10/sec.

Neat viscosity of the gel product form can be measured with a rheometer according to the following method:

• • (1) Load the sample onto the plate.
  • (2) Establish a gap of 1 millimeter between the 1 degree cone and the plate.
  • (3) Perform a shear sweep on the fluid from 0.01/sec to 10/sec.
  • (4) Record the shear stress response of the fluid.
  • (5) Determine the neat viscosity of the fluid by calculating the ratio of shear stress to shear rate at each shear rate.

As noted herein, the personal cleansing composition may include a structured cleansing phase and a benefit phase. In one embodiment, the structured cleansing phase and the benefit phase can be in physical contact. In one embodiment, the personal cleansing composition can be a multiphase personal cleansing composition where the structured cleansing phase and the benefit phase can be blended or mixed to a significant degree, but still be physically distinct such that the physical distinctiveness is undetectable to the naked eye.

In certain embodiments, the personal cleansing composition can be a multiphase personal cleansing composition where the structured cleansing phase and the benefit phase can be made to occupy separate but distinct physical spaces inside a package in which the phases can be stored. In such an embodiment, the structured cleansing phase and the benefit phase can be stored such that the phases are not in direct contact with one another. In another embodiment, the personal cleansing composition can be a multiphase personal cleansing composition where the structured cleansing phase and the benefit phase are in physical contact and can have a striped or marbled configuration.

In yet another embodiment, the personal cleansing composition can include a combination of one or more of the above multiphase personal cleansing compositions. In one such embodiment, one blended multiphase personal cleansing composition can be stacked as stripes with another blended multiphase personal cleansing composition. And in another such embodiment, blended multiphase personal cleansing compositions distinguishable by color can be stacked as stripes wherein the blended multiphase personal cleansing compositions can be otherwise similar.

Test Methods

It is understood that the test methods that are disclosed in the Test Methods Section of the present application should be used to determine the respective values of the parameters of Applicants' invention as such invention is described and claimed herein.

A. C log P

The “calculated log P” (C log P) is determined by the fragment approach of Hansch and Leo (cf., A. Leo, in Comprehensive Medicinal Chemistry, Vol. 4, C. Hansch, P. G. Sammens, J. B. Taylor, and C. A. Ramsden, Eds. P. 295, Pergamon Press, 1990, incorporated herein by reference). C log P values may be calculated by using the “C LOG P” program available from Daylight Chemical Information Systems Inc. of Irvine, Calif. U.S.A.

B. Boiling Point

Boiling point is measured by ASTM method D2887-04a, “Standard Test Method for Boiling Range Distribution of Petroleum Fractions by Gas Chromatography,” ASTM International.

C. Median Particle Size

Particle size is measured using an Accusizer 780A, made by Particle Sizing Systems, Santa Barbara Calif. The instrument is calibrated from 0 to 300μ using Duke particle size standards. Samples for particle size evaluation are prepared by diluting about 1 g of capsule slurry in about 5 g of de-ionized water and further diluting about 1 g of this solution in about 25 g of water.

About 1 g of the most dilute sample is added to the Accusizer and the testing initiated, using the autodilution feature. The Accusizer should be reading in excess of 9200 counts/second. If the counts are less than 9200 additional sample should be added. The accusizer will dilute the test sample until 9200 counts/second and initiate the evaluation. After 2 minutes of testing the Accusizer will display the results, including volume-weighted median size.

The broadness index can be calculated by determining the particle size at which 95% of the cumulative particle volume is exceeded (95% size), the particle size at which 5% of the cumulative particle volume is exceeded (5% size), and the median volume-weighted particle size (50% size—50% of the particle volume both above and below this size). Broadness Index (5)=((95% size)−(5% size)/50% size).

D. Fracture Strength Test Method

Analysis steps include:

a.) Place 1 gram of particles in 1 liter of distilled deionized (DI) water.

b.) Permit the particles to remain in the DI water for 10 minutes and then recover the particles by filtration, using a 60 mL syringe filter, 1.2 micron nitrocellulose filter (Millipore, 25 mm diameter).

c.) Determine the rupture force of 50 individual particles. The rupture force of a particle is determined using the procedure given in Zhang, Z.; Sun, G; “Mechanical Properties of Melamine-Formaldehyde microcapsules,” J. Microencapsulation, vol 18, no. 5, pages 593-602, 2001. Then calculate the fracture strength of each particle by dividing the rupture force (in Newtons) by the cross-sectional area of the respective spherical particle (πr², where r is the radius of the particle before compression), said cross-sectional area being determined as follows: measuring the particle size of each individual particle using the experimental apparatus and method of Zhang, Z.; Sun, G; “Mechanical Properties of Melamine-Formaldehyde microcapsules,” J. Microencapsulation, vol 18, no. 5, pages 593-602, 2001.

d.) Use the 50 independent measurements from c.) above, and calculate the percentage of particles having a fracture strength within the claimed range fracture strength range.

E. Zeta Potential

• • (1) Equipment specifications: Malvern Zeatasizer Nano Model ZEN3600 Sample cell, disposable capillary cell (green cell)
  • (2) Use Duke standards to measure the PSD, and use it to measure the zeta potential to assure that the instrument is functioning properly.
  • (3) Flush a DTS1060 capillary cell with 1-2 mL ethanol, the with DI water to prepare the capillary cell.
  • (4) Sample preparation: first, filter 20 mL DI water through 0.2 micron filter into a 20 mL vial. Add 1 drop (50 microliters of 30 wt % solids particular suspension into the vial and invert the sample back and forth gently until the particulate suspension is homogeneously dispersed in the vial. Next, rinse a DTS1060 green disposable zeta cell with 1-2 mL of DI water, then use a syringe to transfer the sample solution from the vial into the zeta cell, making sure that no air bubbles are present in the cell. Fill the cell to the top, then place a cap on the cell outlet and inlet (again making sure no air bubbles are present in the sample cell). Then, place the cell in the sample chamber, with the electrodes facing the sides of the system. Finally, place the sample cell in the instrument.
  • (5) Conditions for the run:
    • a. Refractive index=1.35 (this number may vary for suspensions. One can measure the refractive index for any particulate suspension using a refractometer)
    • b. Temperature=25 degrees Centigrade
    • c. Equilibration time=1 minute
    • d. Smoluchowski model to be used to calculate the zeta potential
  • (6) Measure each sample in triplicate. The result from the instrument is reported as Zeta Potential in milliVolts, with no extrapolation.

EXAMPLES

While particular embodiments of the present invention have been illustrated and described, it would be obvious to those skilled in the art that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.

A perfume composition, called Scent A, is utilized to prepare the examples of the invention. The table below lists the ingredients, and their properties. Table 2 provides the C log P breakdown of the perfume oil composition.

	TABLE 1
	Material Name	ClogP	Boiling Point ° C.
	Beta Gamma Hexenol	1.3	155
	Phenyl Ethyl Alcohol	1.32	219
	Helional	1.77	329
	Triplal Extra	1.78	199
	Amyl-Acetate (isomer Blends)	1.87	135
	Melonal	2.09	182
	Liffarome	2.14	167
	Iso Eugenol Acetate	2.17	303
	Cis 3 Hexenyl Acetate	2.18	167
	Jasmolactone	2.36	219
	2′6-nonadien-1-ol	2.43	213
	Florosa	2.46	238
	Nonalactone	2.66	193
	Cis Jasmone	2.81	254
	Ethyl Linalool	2.92	223
	Pino Acetaldehyde	2.98	261
	Methyl Dihydro Jasmonate	3.01	323
	Undecavertol	3.06	242
	Azurone 10/tec 0015573	3.06	395
	Dihydro Myrcenol	3.08	195
	Cyclemax	3.23	281
	Hivernal	3.29	351
	Pomarose	3.51	214
	Undecalactone	3.75	228
	Damascenone Total 937459	3.89	267
	Acalea (01-1963)	3.9	344
	Cis-3-hexenyl Salicylate	4	316
	Ionone Beta	4.02	267
	Polysantol	4.21	256
	Ambroxan	4.58	285
	5-cyclohexadecen-1-one	5.04	331
	Iso E Super Or Wood	5.05	325
	Laevo Muscone	5.48	321
	Helvetolide 947650	5.56	309

Example 1

Nonionic Microcapsule (TAS0810101, MVF1837-94B)

An oil solution, consisting of 75 g Fragrance Oil scenta, 75 g of Isopropyl Myristate, 0.6 g DuPont Vazo-52, and 0.4 g DuPont Vazo-67, is added to a 35° C. temperature controlled steel jacketed reactor, with mixing at 1000 rpm (4 tip, 2″ diameter, flat mill blade) and a nitrogen blanket applied at 100 cc/min. The oil solution is heated to 75° C. in 45 minutes, held at 75° C. for 45 minutes, and cooled to 60° C. in 75 minutes.

A second oil solution, consisting of 37.5 g Fragrance Oil, 0.5 g tertiarybutylaminoethyl methacrylate, 0.4 g 2-carboxyethyl acrylate, and 20 g Sartomer CN975 (hexafunctional urethane-acrylate oligomer) is added when the first oil solution reached 60° C. The combined oils are held at 60° C. for an additional 10 minutes.

Mixing is stopped and a water solution, consisting of 56 g of 5% active polyvinyl alcohol Celvol 540 solution in water, 244 g water, 1.1 g 20% NaOH, and 1.2 g DuPont Vazo-68WSP, is added to the bottom of the oil solution, using a funnel.

Mixing is again started, at 2500 rpm, for 60 minutes to emulsify the oil phase into the water solution. After milling is completed, mixing is continued with a 3″ propeller at 350 rpm. The batch is held at 60° C. for 45 minutes, the temperature is increased to 75° C. in 30 minutes, held at 75° C. for 4 hours, heated to 90° C. in 30 minutes and held at 90° C. for 8 hours. The batch is then allowed to cool to room temperature. The finished microcapsules have a median particle size of 6.4 microns, a broadness index of 1.3, and a zeta potential of negative 0.5 millivolts, and a total scent A concentration of 27.6 wt %.

Example 2

Anionic Microcapsule, Large Particle Size (TAS1122101)

Capsules are made using identical materials, compositions, and process conditions as in Example 1 with the following exceptions: 1 gram of Vazo-52, 0.8 grams of Vazo-67, 0.3 grams of tertiarybutylaminoethyl methacrylate, 0.25 grams of 2-carboxyethyl acrylate, and 12 grams of Sartomer CN975 as compositional differences in the oil phase; and 22 grams of 25% active Colloid 351, and 308 grams of water as compositional differences in the water phase. All other mixing and process conditioner remains the same. The finished microcapsules have a median particle size of 10.7 microns, a broadness index of 1.5, and a zeta potential of negative 60 milivolts, and a total scent A concentration of 34.9 wt %.

Example 3

Anionic Microcapsule, Small Particle Size (TAS1123101)

Capsules are made using identical materials, compositions, and process conditions as in Example 1 with the following exceptions: 1 gram of Vazo-52, 0.8 grams of Vazo-67, 1.5 grams of tertiarybutylaminoethyl methacrylate, 1.2 grams of 2-carboxyethyl acrylate, and 60 grams of Sartomer CN975 as compositional differences in the oil phase; and 68 grams of 25% active Colloid 351, and 282 grams of water as compositional differences in the water phase. All other mixing and process conditioner remains the same. The finished microcapsules have a median particle size of 1.4 microns, a broadness index of 1.2, and a zeta potential of negative 60 milivolts, and a total scent A concentration of 20.7 wt %.

Example 4

Anionic Microcapsule (TAS1101101)

Capsules are made using identical materials, compositions, and process conditions as in Example 2 with the following exceptions: 1 gram of tertiarybutylaminoethyl methacrylate, 0.8 grams of 2-carboxyethyl acrylate, and 40 grams of Sartomer CN975 as compositional differences in the oil phase; and 22 grams of 25% active Colloid 351, and 282 grams of water as compositional differences in the water phase. All other mixing and process conditioners remain the same.

The finished microcapsules have a median particle size of 4.8 microns, a broadness index of 1.3, and a zeta potential of negative 60 milivolts, and a total scent A concentration of 23.5 wt %.

Example 5

Body Cleansing Composition

The microcapsules of Example 1, 2, and 4 are formulated into a body cleansing composition. The anionic microcapsules of example 2 and 4 are first mixed with a 15 wt % solution of tapioca starch (Akzo) to form a viscoelastic mixture:

Micro-		15% Tapioca
capsules	Microcapsule	Starch Solution	Water	Final Perfume
of Example	(g)	(g)	(g)	Content wt %
2	4.1	2.38	3.52	14.31%
(Premix 2)
4	6.09	2.38	1.53	14.31%
(Premix 4)

This premix is then added to the body cleansing composition below, mixed at 1900 RPM for 1 minute using a DAFC 400FVZ speed mixer.

	Example	Example	Example	Example
	5A	5B	5C	5D
I: Cleansing Phase
Composition
Sodium Trideceth Sulfate	5.9	5.9	5.9	5.9
(sulfated from Iconol TDA-3
(BASF Corp.) to >95% sulfate)
Sodium Lauryl Sulfate	5.9	5.9	5.9	5.9
(Procter and Gamble)
Sodium Lauroamphoacetate	3.6	3.6	3.6	3.6
(Cognis Chemical Corp.,)
Guar Hydroxypropyltrimonium	0.3	0.3	0.7	0.7
Chloride
(N-Hance 3196 from Aqualon)
Stabylen 30	0.33	0.33	0.33	0.33
(Acrylates/Vinyl Isodecanoate,
3V)
Sodium Chloride	3.75	3.75	3.75	3.75
Trideceth-3	1.75	1.75	1.75	1.75
(Iconal TDA-3 from BASF Corp.)
Methyl chloro isothiazolinone and	0.033	0.033	0.033	0.033
methyl isothiazolinone (Kathon
CG, Rohm & Haas)
EDTA (Dissolvine NA 2x)	0.15	0.15	0.15	0.15
Sodium Benzoate	0.2	0.2	0.2	0.2
Citric Acid, titrate	pH = 5.7 ± 0.2	pH = 5.7 ± 0.2	pH = 5.7 ± 0.2	pH = 5.7 ± 0.2
Scent A	0.4	0.0	0.0	0.0
Perfume Microcapsule Example	None	1	Premix 2	Premix 4
Polyacrylate Microcapsule Premix	0	1.45	1.40	1.40
(0.4% perfume usage level)
Water and Minors (NaOH)	Q.S.	Q.S.	Q.S.	Q.S.
II: Benefit Phase Composition
Petrolatum	70	70	70	70
(G2218 from Sonnerbonn)
Mineral Oil	30	30	30	30
(Hydrobrite 1000 from
Sonnerbonn)
III: Surfactant Phase:Benefit	50:50	50:50	50:50	50:50
Phase Blending Ratio

Each product above is tested for olfactive performance on a forearm, using the following protocol:

• • Saturate puff under running water for 5 seconds. (95 deg. F+/−5 deg. F.; ˜1.8 L/min)
  • Wet forearm under running water for 5 seconds, elbow to wrist.
  • Dispense 1 mL product(s) into opposite palm.
  • Rub product on application arm for 5 seconds. Rub palm along the edge of arm to remove excess from palm.
  • Do NOT rewet puff. LIGHTLY wash the inner forearm for 10 seconds in long, circular strokes. It should foam, if it's streaking, lighten pressure.
  • Allow 15 second residence time.
  • Rinse forearm with running water for 15 seconds.
  • Dry with clean paper towels by laying paper towel on lower arm and walking opposite hand along full, inner arm (elbow to wrist), no rubbing.
  • Perform no measurements for at least 30 seconds, leaving arm open to air during this time.
  • Evaluate the olfactive performance of the arm before rubbing and after rubbing, for different periods of aging the arm (and exposing to ambient air).Intensity Scale 1-100 (No Odor-Most Intense Possible)

		Initial Dry	4 hr	6 hr	8 hr
	During	Pre-rub/	Pre-rub/	Pre-rub/	Pre-rub/
Example	Use/Lather	Post-rub	Post-rub	Post-rub	Post-rub
5A	75	70/70	50/50	40/40	30/30
5B	75	70/70	50/50	40/40	30/30
5C	70	65/70	50/65	40/50	30/40
5D	70	65/65+	50/60+	40/50	30/40

Notice the much higher intensity of fragrance is detected at each fragrance longevity time point (vs. control 4A) when premixes of anionic microcapsule and cationic polymer are added to the body cleansing composition.

The dimensions and values disclosed herein are not to be understood as being strictly limited to the exact numerical values recited. Instead, unless otherwise specified, each such dimension is intended to mean both the recited value and a functionally equivalent range surrounding that value. For example, a dimension disclosed as “40 mm” is intended to mean “about 40 mm.”

Every document cited herein, including any cross referenced or related patent or application, is hereby incorporated herein by reference in its entirety unless expressly excluded or otherwise limited. The citation of any document is not an admission that it is prior art with respect to any invention disclosed or claimed herein or that it alone, or in any combination with any other reference or references, teaches, suggests or discloses any such invention. Further, to the extent that any meaning or definition of a term in this document conflicts with any meaning or definition of the same term in a document incorporated by reference, the meaning or definition assigned to that term in this document shall govern.

While particular embodiments of the present invention have been illustrated and described, it would be obvious to those skilled in the art that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.

Claims

1. A personal cleansing composition comprising: (a) a premix, the premix comprising from about 0.001% to about 10%, by weight of the personal cleansing composition, of an anionic charged polyacrylate microcapsuleand from about 0.01% to about 2% of a cationic deposition polymer;(b) from about 2% to about 50% of a detersive surfactant; and(c) a carrier.

2. The personal cleansing composition of claim 1, wherein the anionic charged polyacrylate microcapsule comprises an anionic emulsifier and a polyacrylate microcapsule.

3. The personal cleansing composition of claim 2, wherein the anionic emulsifier surrounds at least a part of the external surface of the polyacrylate microcapsule, or is physically or chemically bound to the external surface of the polyacrylate microcapsule.

4. The personal cleansing composition of claim 2, wherein the anionic emulsifier and the polyacrylate microcapsule are mixed such that the weight ratio of the anionic emulsifier to the polyacrylate microcapsule is from about 1.0:40 to about 0.5:5.

5. The personal cleansing composition of claim 1, wherein the anionic charged polyacrylate microcapsule and the cationic deposition polymer are mixed such that the weight ratio of the anionic charged polyacrylate microcapsule to the cationic deposition polymer is from about 1.0:0.01 to about 1.0:10.

6. The personal cleansing composition of claim 2, wherein the anionic emulsifier is selected from the group consisting of: poly(meth)acrylic acid; copolymers of (meth)acrylic acids and its (meth)acrylates with C1-C22 alkyl; copolymers of (meth)acrylic acids and (meth)acrylamide; and mixtures thereof.

7. The personal cleansing composition of claim 1, wherein the anionic charged polyacrylate microcapsule has a particle size of from about 2 microns to about 80 microns.

8. The personal cleansing composition of claim 2, wherein the polyacrylate microcapsule has a core and a shell that encapsulates said core.

9. The personal cleansing composition of claim 8, wherein the core comprises from about 6% to about 99.9% of a benefit agent.

10. The personal cleansing composition of claim 9, wherein the benefit agent is selected from the group consisting of perfumes; brighteners; enzymes; skin care agents, moisturizers, thickeners; anti-microbial agents and mixtures thereof.

11. The personal cleansing composition of claim 1, wherein the cationic deposition polymer is selected from the group consisting of starches, guar, cellulose, cassia, locust bean, Konjac, Tara, galactomanna, hydroxypropyltrimonium chloride modified guar guam, polyDADMAC, tapioca starch, and polyTriquat.

12. The personal cleansing composition of claim 1, wherein the cationic deposition polymer is a water-soluble polymer with a charge density of from about 0.5 milliequivalents per gram to about 12 milliequivalents per gram, and wherein the cationic deposition polymer has a molecular weight of about 100,000 Daltons to about 5,000,000 Daltons.

13. The personal cleansing composition of claim 1, wherein the detersive surfactant is anionic, nonionic, cationic, zwitterionic, amphoteric, soap, or combinations thereof.

14. The personal cleansing composition of claim 1, wherein the carrier comprises water and water solutions of lower alkyl alcohols and polyhydric alcohols.

15. The personal cleansing composition of claim 1, wherein the anionic charged polyacrylate microcapsule is contained in an agglomerate, and wherein the agglomerate comprises materials selected from the group consisting of silicas, citric acid, sodium carbonate, sodium sulfate, sodium chloride, and binders such as sodium silicates, modified celluloses, polyethylene glycols, polyacrylates, polyacrylic acids, zeolites, and mixtures thereof.

16. The personal cleansing composition of claim 1, wherein the personal cleansing composition is in the form of a gel, and wherein the gel comprises less than about 45% water.

17. The personal cleansing composition of claim 2, wherein the anionic emulsifier and the polyacrylate microcapsule are mixed such that the weight ratio of the anionic emulsifier to the polyacrylate microcapsule is from about 1.0:200 to about 1:20.

18. The personal cleansing composition of claim 2, wherein the anionic emulsifier and the polyacrylate microcapsule are mixed such that the weight ratio of the anionic emulsifier to the polyacrylate microcapsule is from about 1.0:1000 to about 2:5.

19. The personal cleansing composition of claim 2, wherein the anionic emulsifier is selected from the group consisting of: carboxyvinylpolymer; acrylate copolymers; Acrylic acid/vinyl ester copolymer/Acrylates/Vinyl Isodecanoate crosspolymer; Acrylates/Palmeth-25 Acrylate copolymer; Acrylate/Steareth-20 Itaconate copolymer; Acrylate/Celeth-20 Itaconate copolymer; Polystyrene sulphonate; copolymers of methacrylic acid and acrylamidomethylpropane sulfonic acid; copolymers of acrylic acid and acrylamidomethylpropane sulfonic acid; carboxymethycellulose; carboxy guar; copolymers of ethylene and maleic acid; acrylate silicone polymer; and mixtures thereof.

20. A personal cleansing composition comprising: a premix, the premix comprising from about 0.001% to about 10% of an anionic polyacrylate microcapsule andfrom about 0.01% to about 2% of a cationic deposition polymer;from about 2% to about 50% of a detersive surfactant; anda carrier;wherein said anionic polyacrylate microcapsule comprises an oil soluble or dispersible core material and a wall material at least partially surrounding the core material, the microcapsule wall material comprising: the reaction product of a first composition in the presence of a second composition comprising an anionic emulsifier, the first composition comprising a reaction product of i) an oil soluble or dispersible amine with ii) a multifunctional acrylate or methacrylate monomer or oligomer, an oil soluble acid and an initiator, the anionic emulsifier comprising a water soluble or water dispersible acrylic acid alkyl acid copolymer, an alkali or alkali salt, and optionally a water phase initiator, whereby the reaction product of the first composition and second composition results in the formation of microcapsules.